Skip to main content
A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Not on Concomitant Methotrexate. Genovese, M. C., Greenwald, M., Codding, C., Cardiel, M. H., Zubrzycka-Sienkiewicz, A., Kivitz, A. J., Wisseh, S., Shay, K., Garg, J. P. WILEY-BLACKWELL. 2014: S1234–S1235

View details for Web of Science ID 000344384906061